Adult nephrotic syndrome: Non-specific strategies for treatment

Nephrology

Volumn 13, Issue 1, 2008, Pages 45-50

  Charlesworth, John A ^a,b   Gracey, David M ^a   Pussell, Bruce A ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Bone mineral density; Hyperlipidaemia; Infection; Nephrotic syndrome; Proteinuria; Thrombo embolism

Indexed keywords

ALBUMIN; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PNEUMOCOCCUS VACCINE;

BONE DENSITY; DRUG EFFICACY; DRUG SAFETY; EDEMA; HUMAN; HYPERLIPIDEMIA; INFECTION; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ANTILIPEMIC AGENTS; BACTERIAL VACCINES; HUMANS; HYPERLIPIDEMIAS; INFECTION; NEPHROTIC SYNDROME; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; PROGNOSIS; PROTEINURIA; RISK FACTORS; THROMBOEMBOLISM;

EID: 38149091943     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00890.x     Document Type: Review

References (21)

1. Bernard DB. Extrarenal complications of the nephrotic syndrome. Kidney Int. 1988 33 : 1184 202.
2. Bernard DB. Metabolic abnormalities in nephrotic syndrome: pathophysiology and complications. In : Brenner GM, Stein JH (eds). Nephrotic Syndrome. New York : Churchill Livingstone, 1982 85 120.
3. Kaysen G, Gambertoglio J, Felts J, Hutchison F. Albumin synthesis, albuminuria and hyperlipidemia in nephrotic syndrome. Kidney Int. 1987 31 : 1368 76.
4. Praga M, Borstein B, Andres A et al. Nephrotic proteinuria without hypoalbuminemia: Clinical characteristics and response to angiotensin-converting enzyme inhibitor. Am. J. Kidney Dis. 1991 17 : 330 8.
5. Ponticelli C, Passerini P. Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int. 1994 46 : 595 604.
6. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Thrombosis and hemostasis in renal disease. Kidney Int. 1994 46 : 287 96.
7. Robert A, Olmer M, Sampol J, Gugliotta JE, Casanova P. Clinical correlation between hypercoagulability and thrombo-embolic phenomena. Kidney Int. 1987 31 : 830 5.
8. Bellomo R., Wood C, Wagner I et al. Idiopathic membranous nephropathy in an Australian population: The incidence of thrombo-embolism and its impact on the natural history. Nephron 1993 63 : 240 1.
9. Sarasin FP, Schifferli JA. Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy. Kidney Int. 1994 45 : 578 85.
10. Fuchshuber A, Kühnemund O, Keuth B, Lütticken R, Michalk D, Querfeld U. Pneumococcal vaccine in children and young adults with chronic renal disease. Nephrol. Dial. Transplant. 1996 11 : 468 73.
11. Giangiacomo J, Cleary TG, Cole BR, Hoffsten P, Robson AM. Serum immunoglobulins in the nephrotic syndrome. N Engl. J. Med. 1975 293 : 8 12.
12. McLean RH, Forsgren A, Björkstèn B, Kim Y, Quie PG, Michael AF. Decreased serum factor B concentration associated with decreased opsonization of Escherichia coli in the idiopathic nephrotic syndrome. Pediatr. Res. 1977 11 : 910.
13. Wheeler DC, Bernard DB. Lipid abnormalities in nephrotic syndrome. Am. J. Kidney Dis. 1994 23 : 331 46.
14. Staphrans J, Anderson CD, LurZ. FW, Felts JM. Separation of a lipoprotein lilpase cofactor from the alpha I-acid glycoprotein fraction from urine of nephrotic patients. Biochim. Biophys. Acta 1980 617 : 514 23.
15. Kaysen GA, Don B, Schambelan M. Proteinuria, albumin synthesis and hyperlipidemia in the nephrotic syndrome. Nephrol. Dial. Transplant. 1991 6 : 141 9.
16. Thomas ME, Harris KPG, Ramaswamy C et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int. 1993 44 : 1124 9.
17. D'Amico G, Gentile MG, Mann G et al. Effect of vegetarian soy diet on hyperlipidaemia in nephrotic syndrome. Lancet 1992 339 : 1131 4.
18. Gansevoort RT, de Zeeuw D, de Jong PE. Dissociation between the course of the hemodynamic antiproteinuric effects of angiotensin I converting enzyme inhibition. Kidney Int. 1993 44 : 579 84.
19. Gansevoort RT, Sluiter WI, Hemmelder MH, de Zeeuw D, de Jong PE. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials. Nephrol. Dial. Transplant. 1995 10 : 1963 74.
20. Gulati S, Godbole M, Singh U, Gulati K, Srivastava A. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am. J. Kidney Dis. 2003 41 : 1163 9.
21. Elder G. Nephrotic Syndrome - don't forget the bones Nephrology 2008 13 : 38 9.